EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY 4.0

CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting

Kelly Lim iD, Winnie L Kan iD, Pramod C Nair iD, Monika Kutyna, Angel F Lopez, Timothy Hercus iD, David M Ross, Steven Lane, Chun Yew Fong iD, Anna Brown, Agnes Yong, David Yeung und 3 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310641 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift PLOS ONE, 2024. Verfasst von Kelly Lim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Medicine, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-cbl, Leukemia, Myelomonocytic, Chronic, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukemia and Lymphoma Society, Commonwealth Serum Laboratories, Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myelomonocytic leukemia (CMML) is a rare blood cancer of older adults (3 in every 1,000,000 persons) characterized by poor survival and lacking effective mutation-specific therapy. Mutations in the ubiquitin ligase Cbl occur frequently in CMML and share biological and molecular features with a clonal disease occurring in children, juvenile myelomonocytic leukemia (JMML). Here we analyzed the clinical presentations, molecular features and immunophenotype of CMML patients with CBL mutations enrolled in a prospective Phase II clinical trial stratified according to molecular markers. Clinically, CBL mutations were associated with increased bone marrow blasts at diagnosis, leukocytosis and splenomegaly, similar to patients harboring NRAS or KRAS mutations. Interestingly, 64% of patients presented with more than one CBL variant implying a complex subclonal architecture, often with co-occurrence of TET2 mutations. We found CBL mutations in CMML frequently clustered in the RING domain in contrast to JMML, where mutations frequently involve the linker helix region ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-cblLeukemia, Myelomonocytic, ChronicMutationHumansMaleFemaleAgedMiddle AgedLeukemia, Myelomonocytic, JuvenileAged, 80 and overAdultDioxygenasesDNA-Binding ProteinsProspective Studies

Substanzen

Proto-Oncogene Proteins c-cblCBL protein, humanDioxygenasesTET2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Discipline of Medicine, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Adelaide, SA, Australia.
  • Cytokine Receptor Laboratory, SA Pathology, Adelaide, SA, Australia.
  • College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia.
  • SA Pathology, Adelaide, SA, Australia.
  • Department of Hematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia.

ORCID-Profile: Kelly Lim, Winnie L Kan, Pramod C Nair, Timothy Hercus, Chun Yew Fong, Daniel Thomas

Förderung

  • Leukemia and Lymphoma Society
  • Commonwealth Serum Laboratories
  • Medical Research Future Fund
  • National Health and Medical Research Council
  • Snowdome Foundation
  • Leukaemia Foundation

Zitieren

APA

Lim, K., Kan, W. L., Nair, P. C., Kutyna, M., Lopez, A. F., Hercus, T., Ross, D. M., Lane, S., Fong, C. Y., Brown, A., Yong, A., Yeung, D., Hughes, T., Hiwase, D., & Thomas, D. (2024). CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. PLOS ONE. https://doi.org/10.1371/journal.pone.0310641

Vancouver

Lim K, Kan WL, Nair PC, Kutyna M, Lopez AF, Hercus T, et al. CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. PLOS ONE. 2024. doi:10.1371/journal.pone.0310641

BibTeX
@article{Lim2024,
  author = {Lim, Kelly and Kan, Winnie L and Nair, Pramod C and Kutyna, Monika and Lopez, Angel F and Hercus, Timothy and Ross, David M and Lane, Steven and Fong, Chun Yew and Brown, Anna and Yong, Agnes and Yeung, David and Hughes, Timothy and Hiwase, Devendra and Thomas, Daniel},
  title = {CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310641}
}
Kostenlos starten →